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Abstract
Ultrasound-assisted transdermal insulin delivery offers a less painful and less 
invasive alternative to subcutaneous insulin injections. However, ultrasound-
based drug delivery, otherwise known as sonophoresis, is a highly variable 
phenomenon, in part dependent on cavitation. The aim of the current work is to 
investigate the role of cavitation in transdermal insulin delivery. Fluorescently 
stained, soluble Actrapid insulin was placed on the surface of human 
skin-mimicking materials subjected to 265 kHz, 10% duty cycle focused 
ultrasound. A confocally and coaxially aligned 5 MHz broadband ultrasound 
transducer was used to detect cavitation. Two different skin models were used. 
The first model, 3% agar hydrogel, was insonated with a range of pressures 
(0.25–1.40 MPa peak rarefactional focal pressure—PRFP), with and without 
cavitation nuclei embedded within the agar at a concentration of 0.05% w/v. 
The second, porcine skin was insonated at 1.00 and 1.40 MPa PRFP. In both 
models, fluorescence measurements were used to determine penetration depth 
and concentration of delivered insulin. Results show that in agar gel, both 
insulin penetration depth and concentration only increased significantly in the 
presence of inertial cavitation, with up to a 40% enhancement. In porcine 
skin the amount of fluorescent insulin was higher in the epidermis of those 
samples that were exposed to ultrasound compared to the control samples, 
but there was no significant increase in penetration distance. The results 
underline the importance of instigating and monitoring inertial cavitation 
during transdermal insulin delivery.
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1. Introduction 
Transdermal insulin delivery offers an alternative to conventional insulin delivery methods 
such as pens and insulin pumps by reducing pain and the chance of infection (Mitragotri 
et al 1995, Khafagy et al 2007). For transdermal delivery to be effective, the drug needs to 
penetrate the natural barriers of the skin. The stratum corneum, the outermost layer of the 
skin is the biggest barrier inhibiting the penetration of insulin through the skin (Boucaud et al 
2000, Mitragotri et al 2000, Al-Bataineh et al 2011, Saroha et al 2011); however, recent stud-
ies have shown that the full epidermis, not just the stratum corneum is responsible for the low 
permeability of skin (Andrews et al 2013). This finding is important for drugs like insulin that 
need to reach systemic circulation to perform their function.
The last two decades have seen an exponential increase in the study of ultrasound for 
enhancing the transdermal transport of a variety of drugs and vaccines, otherwise known as 
sonophoresis (Levy and kost 1989, Mitragotri et al 1996, Boucaud et al 2000, Tezel et al 
2001, Terahara et al 2002, Smith et al 2003, Prausnitz et al 2004, Ogura et al 2008, Ueda 
et al 2009, Al-Bataineh et al 2011, Kalluri and Banga 2011). The most studied drug is insulin, 
a 5.6 kDa protein, which is crucial for the wellbeing of type one diabetes mellitus patients. 
Although low-frequency ultrasound (20–100 kHz) has been shown to be an effective means of 
transdermal drug delivery (Boucaud et al 2000, Prausnitz et al 2004, Ogura et al 2008, Polat 
et al 2011), in recent years there has been a shift towards middle (100–200 kHz) (Al-Bataineh 
et al 2011) and high (1–3 MHz) frequencies (Mitragotri et al 1995, Pitt et al 2004). In addi-
tion to ultrasound exposure parameters such as frequency and intensity, it is also important to 
distinguish between ultrasound waves being applied prior to placement of the drug carrier on 
the skin (pretreatment sonophoresis) or after placement (simultaneous sonophoresis) (Ogura 
et al 2008, Polat et al 2011).
One difficulty with transdermal drug delivery compared with hypodermic needle injec-
tion is the uncertainty in delivered dose. This issue is especially important in insulin delivery 
(Pearson 2010), where international organization for standardizations (ISO) standards require 
that dose accuracy be within 10% at 10 insulin units (IU) and 5% at 30 IU (Händel et al 2008). 
The measurement of electrical impedance has been shown to be a viable method of monitor-
ing tissue permeability (Mitragotri et al 2000, Tezel et al 2001, Terahara et al 2002), though 
such measurements are not able to return accurate values of delivered dose. One possible 
strategy in reducing dose uncertainty is relying on a phenomenon that enables delivery of 
over 90% of insulin. Cavitation has been shown to be one of the main phenomena involved in 
sonophoresis, (Prausnitz et al 2004) and a number of studies have found correlations between 
the amount of acoustic cavitation and the delivery achieved. However, these studies have not 
attempted to quantitatively determine the relationship between the distribution and concen-
tration of ultrasound-enhanced delivery of insulin or any other drug candidate and cavitation 
activity present during delivery. The current work therefore explores the relationship between 
acoustic cavitation emissions and final distributions of self-stained fluorescent Actrapid insu-
lin in two tissue-mimicking materials, agar gel and porcine skin.
Though the effects of cavitation in drug delivery have been previously studied, the work 
serves to better quantify distribution as a function of cavitation activity to better our physical 
understanding of this phenomenon (Mitragotri et al 2000, Tang et al 2002, Chen et al 2003, 
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Frenkel 2008, Ueda et al 2009, Rifai et al 2010, Arvantis et al 2011, Mo et al 2012, Lai et al 
2013). In a recent study (Bhatnagar et al 2014), inertial cavitation was identified as the domi-
nant mechanism for ultrasound-mediated transport of molecules in agar gels, having a consid-
erably greater impact than either acoustic radiation force or small levels of heating (<2° C). In 
the present work, the applicability of cavitation-mediated transport to enhancing the delivery 
of insulin is investigated, through quantification of the level of cavitation activity over a range 
of ultrasound exposure regimes in agar and porcine skin.
2. Materials and methods
2.1. Overview
The current sub-section gives an overview of the general experimental setup, as shown sche-
matically in figure  1. A high intensity focused ultrasound (HIFU) transducer insonated a 
sample containing a donor layer with fluorescently stained insulin (see section 2.2) and an 
acceptor layer containing either agar gel or porcine skin (described in sections 2.3, 2.4, respec-
tively). The insonation happened at various pressures; the employed pressures as well as other 
settings are detailed in section 2.5. Broadband emissions created by inertial cavitation events 
were captured by a broadband transducer called a passive cavitation detector, as described in 
section 2.6. These recordings were then compared with insulin fluorescence measurements 
that described the spatial distribution of delivered insulin concentration, as detailed in sec-
tion 2.7. The entire experimental setup was placed in a water tank with deionized, filtered 
water at room temperature and fitted with a 3D micropositioning system to aid alignment.
2.2. Sample preparation—fluorescently-stained insulin
Actrapid insulin is a neutral, fast acting crystalline insulin. It is the only insulin on the market 
that is a clear solution, all others being suspensions. This quality makes it ideal for trans-
dermal delivery as well as fluorescent staining. Actrapid insulin (Actrapid Vial 100 IU ml−1 
solution for injection, Novo Nordisk Ltd, Denmark) was stained with 5-Carboxyflurescein 
N-succinimidyl ester (CFSE) (Sigma Aldrich, UK) in a ratio of 5 CFSE molecules to 1 insulin 
molecule for optimal fluorescent visualization. 5 mg CFSE was dissolved in 1 mL dimethyl-
sulfoxide (DMSO) (Sigma-Aldrich, UK), while 1600 µl insulin was dissolved in 8.8 ml 
phosphate buffered saline (PBS) (Sigma-Aldrich, UK). The two solutions were mixed and 
shaken for 1 h before filtering with a 3 kDa filter (Amicon Ultra 0.5 ml centrifugal filter, EMD 
Millipore, MA, USA) to increase insulin concentration and filter out unbound CFSE. The 
solution was centrifuged up to 8–10 times, each time for a duration of 10 min at a speed of 
14 000 rpm, washing with PBS until the liquid in the upper filter compartments turned clear.
Molecular size was determined using Dynamic Light Scattering (DLS) (Zetasizer Nano 
ZS, laser wavelength 633 nm; Malvern Instruments, UK) before and after staining, in order to 
rule out the formation of aggregates. The stained insulin molecules had a diameter of 5–7 nm, 
which was similar to the 5–6 nm diameter of the pure unstained insulin molecules. The final 
concentration of stained insulin solution was determined using UV/Vis absorbance measure-
ments (FLUOStar Omega, BMG Labtech, Germany), and ranged from 3.72 to 4.72 mg ml−1.
2.3. Sample preparation—agar hydrogel
The agar sample consisted of a donor and an acceptor layer, housed in a cylindrical Perspex 
holder described in an earlier publication (Bhatnagar et al 2014). Briefly, the inner dimensions 
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of the holder were 10 mm diameter, and 30 mm length, 4 mm of which was occupied by the 
donor layer, and 26 mm by the acceptor layer. The axis of the cylinder was aligned with the 
HIFU axis.
The acceptor layer—prepared by dissolving 3% w/v agar (UltraPure Agarose 1000, 
Invitrogen, Paisley, UK) in distilled, deionized water and heated until all of the agar powder 
had dissolved. The liquid solution was then degassed at a pressure of −0.5 bar for 45 min at 
a temperature of 70 °C and then immediately dispensed using a pipette into a Perspex holder 
described earlier (Bhatnagar et al 2014). Agar at this concentration has speed of sound and 
density that are close to human tissue (Condliffe 2009).
To prepare the donor layer, the agar powder was mixed at a 0.5% w/v concentration with 
0.9% w/v PBS solution (Dulbecco’s PBS 1%, Life Technologies, Paisley, UK) and was heated 
until the agar powder fully dissolved. After degassing and cooling the gel to a temperature of 
40 °C, the fluorescently-stained insulin solution described earlier was added to the solution, so 
that the end insulin concentration of the donor layer was 100 µg ml−1. 300 µl of donor solution 
was used for each sample, so that 30 µg of insulin or 0.864 IU were contained in each donor 
layer. Although this is on the lower end of the scale of insulin doses normally delivered to a 
diabetes patient, this concentration was the highest that could avoid fluorescent imaging satu-
ration. Samples were placed in a 4 °C fridge between the casting of the donor and acceptor 
layers for 2 h, and after the casting of the acceptor layer for 1 h to aid the agar gelling process.
Artificial cavitation nuclei have been previously shown to lower the inertial cavitation 
threshold and to increase the cavitation activity in ultrasound-exposed media (Gyöngy 2010). 
Such artificial nuclei can take the form of ultrasound contrast agent microbubbles (Arvantis 
et al 2011), or solid gas-entrapping microparticles such as talcum powder (Rifai et al 2010). 
At the combination of pressure and frequency chosen (0.256 MHz, 0.6–1.4 MPa), ultrasound 
contrast agent microbubbles are almost instantly destroyed (Arvantis et al 2011), which would 
result in varying levels of cavitation activity over the exposure duration. Furthermore, the 
Figure 1. Schematic of the experimental setup. The HIFU transducer was driven by 
a signal originating from a function generator and amplified by a power amplifier. 
A matching network was used to optimize power transmission to the HIFU transducer. A 
passive cavitation detector (confocally aligned with the HIFU transducer) was used to 
detect cavitation at the focus of the HIFU beam. The signal from the PCD was filtered 
using a 2 MHz high-pass filter, amplified and then recorded using a data acquisition 
system for further analysis.
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buoyancy of microbubbles makes it difficult to ensure an even spatial distribution over the 
entire surface area of the sample. By contrast, talc microparticles provide a stable supply of 
cavitation nuclei that enables cavitation activity to be maintained throughout the ultrasound 
exposure (Bhatnagar et al 2014). Based on this observation, talcum powder (86255, particle 
size >44 µm, Sigma-Aldrich, UK) at a concentration of 0.05% w/v was added to the donor 
layer before solidification of the agar to half of the agar samples. These samples were used to 
investigate the effect of cavitation in insulin transport enhancement.
2.4. Sample preparation—porcine skin
Porcine skin was chosen as a human skin model based on the following considerations 
(Coussios and Roy 2008): the thickness of different layers are similar to the human skin; 
the elastic properties and cellular composition are comparable; the speed of sound—around 
1720 m s−1—is not significantly higher than in human skin, which varies between 1498 and 
1650 m s−1. Experiments were performed using full thickness porcine skin. The skin was har-
vested from the medial thigh of female Landrace pigs, weighing 40–50 kg immediately after 
sacrifice. Samples were shaved and the fat was removed and cut into 40  ×  40 mm pieces and 
stored in a −20 °C freezer up to a week. Just prior to an experiment skin was thawed at room 
temperature and then mounted in a Perspex holder. Figure 2 shows photographs of the custom-
made Perspex holder used to house the porcine skin samples. From the direction of the HIFU 
transducer, the holder contains the following layers: a golden-colored, donor layer containing 
agar and insulin acting as the insulin carrier; porcine skin; transparent, degassed, isotonic 
saline to provide humidity for porcine skin; and a blue polyurethane ultrasound absorber to 
avoid reflections of the HIFU beam. Saline was used at room temperature, however heating it 
to body temperature can result in a lower cavitation threshold. The donor layer was prepared 
in the same manner as in the section 2.3, with the exception that the diameter was 8 mm and 
the thickness was 6 mm. Cavitation nuclei were not used in this part of the study.
2.5. Ultrasound exposure
A 265 kHz, single-element HIFU transducer (H117D, S/N –001, Sonic Concepts, USA) was 
used for sonication. The transducer had a 64 mm aperture and 63 mm focal length, and con-
tained a 16 mm diameter hole in the center to accommodate the co-axial placement of a pas-
sive cavitation detector (PCD). The transducer was driven by an RF power amplifier (1040 L, 
Electronics and Innovation, Rochester, NY, USA) whose input signal was provided by a func-
tion generator (33220 A, Agilent, Santa Clara, CA. USA). The amplifier output impedance 
was matched to the HIFU transducer through a customized matching network
The focus of the transducer was aligned with the surface of the donor layer. Samples were 
first aligned to the ultrasound focus using the PCD transducer driven with a pulser- receiver 
(DPR300 Pulser Receiver, Imaginant, Pittsford, NY, USA) to monitor the position of the sam-
ple until its surface was at the focus. Once positioned at the focus, the samples were exposed 
to 100 cycles of 10% duty-cycle ultrasound insonation (10 ms on, 90 ms off), giving a total 
exposure time of 10 s. These parameters were chosen in order to minimize heating effects. 
Cavitation is known to be a phenomenon that only occurs above a certain rarefactional pres-
sure threshold (Coussios and Roy 2008), hence all pressures quoted in this article will be 
referring to the peak rarefactional focal pressure (PRFP). Pressures were determined using a 
prior calibration of the HIFU transducer by a fellow member of the laboratory, using a cali-
brated needle hydrophone (Onda placed at the HIFU focus. To ensure a variety of exposures 
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with and without the occurrence of cavitation, a large range of pressures (0.25, 0.45, 0.65, 
1.00, 1.40 MPa) was used in agar. Based on the results in agar, 1.00 and 1.40 MPa was used 
for porcine skin. Three exposures were carried out for each parameter setting.
2.6. Quantification of inertial cavitation
A 13 mm aperture PCD (V309-SU, PZT element, Olympus Industrial, Southend-On-Sea, 
UK) detected inertial cavitation by capturing broadband acoustic emissions during ultrasound 
exposure. It had a central frequency of 5 MHz and a 111% −6 dB bandwidth. The PCD was 
placed inside a hole running through the central axis of the HIFU transducer (see section 2.5), 
and the PCD focus was aligned with the HIFU focus to ensure optimal capture of cavitation 
events.
To record the cavitation, the signal received by the PCD was first filtered with a 2 MHz 
high-pass filter (Allen Avionics, USA) in order to remove the harmonics of the 265 kHz 
insonation frequency. The filtered signal was then amplified 25 times using two passes of 
a 4-channel, 0–350 MHz response, 5 ×  preamplifier (SR445A, Stanford Research Systems, 
Sunnyvale, California) and digitized using a 14 bit data acquisition (DAQ) card (PCI-5122, 
National Instruments, Austin, Texas) operating at a sampling frequency of 100 MHz. The 
DAQ card was set to record synchronously with the HIFU pulses using an output trigger from 
the function generator, recording a 200 µs segment for each pulse.
To quantify the level of inertial cavitation, digital filtering was applied to remove the har-
monics and sub-harmonics of the signal and leave a voltage signal V containing only the 
Figure 2. Phantom holders and acoustic alignment of skin models used. The agar skin 
model (top row) was cylindrical and positioned with the surface of the donor layer at the 
ultrasound focus. The donor layer in the custom-made Perspex holder for porcine skin 
(bottom row) was filled with 0.5 w/v% agar hydrogel containing fluorescent insulin at a 
concentration of 100 μg ml−1. The skin was placed between the donor and acceptor layer 
using epoxy glue and screws. The acceptor layer was filled with isotonic saline in order 
to provide osmotic conditions close to that in the body. The HIFU beam was focused at 
the surface of donor layer.
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broadband component. The variance of V was calculated for each 200 µs segment and then 
integrated over time to produce a so-called cavitation dose measure, with units of V2s that are 
proportional to energy (Hockham et al 2010).
2.7. Quantification of insulin delivery
For quantification of insulin delivery in agar, the agar samples were removed from their 
Perspex moulds and a 2 mm thick slice was cut out along the plane of the HIFU axis (and 
thus HIFU focus) using a pair of blades. After removal of the donor layer to avoid image 
saturation, each slice was mounted on a microscopic slide and analyzed under a fluorescent 
microscope (Nikon Eclipse Ti, Nikon Instruments, Melville, NY, USA) to determine the insu-
lin concentration and penetration depth in the acceptor layer. Images were taken from each 
sample under the same exposure settings and ImageJ software (National Institute of Health, 
Bethesda, Massachusetts) was used to determine the fluorescent intensities.
A fluorescence calibration curve was used to convert the detected fluorescent intensities 
onto insulin concentrations. The average insulin concentration was calculated in the top 2 mm 
penetration depth of each of the samples from the average fluorescent intensity present in that 
area. Penetration distance was defined as the maximum depth from the surface of a sample 
where fluorescence was above the fluorescence of pure agar.
In the case of porcine samples, each sample was immediately removed from its holder 
following HIFU exposure and a 3  ×  3 mm piece was cut around the site of the HIFU focus. 
Samples were quick-frozen using hexane and dry ice to avoid the formation of ice-crystals. 
Pieces were stored in a −20 °C fridge for up to 2–3 d. Samples were removed from the fridge 
and stored in dry ice until they were embedded with Tissue–Tek OCT compound (Fisher 
Scientific, MA, USA) for sectioning with a cryostat. 30 µm-thick pieces were cut from each of 
the samples using a cryostat, and then placed onto microscopic slides. Samples were embed-
ded with a mounting medium (Vectashield Mounting Media, Vector Laboratories, California) 
to help prolonged storage and inhibit photobleaching during fluorescence imaging.
In contrast to the agar samples, the background fluorescence changed with each sample. 
Therefore, the peak penetration distance was found unreliable. A measure of effective penetra-
tion distance (EPD) was defined instead. This measure was calculated as the mean distance 
value for the normalized (probability) distribution of fluorescent intensities with distance, 
evaluated over the distance range of 0 to 400 μm from the skin surface. The average fluores-
cent intensities were also evaluated over this distance range.
3. Results and discussion
3.1. Results in agar—cavitation dose, transport enhancement
Figure 3 shows the cavitation doses recorded at different pressures. The cavitation threshold 
is defined as the lowest peak rarefactional pressure amplitude at which the level of broad-
band emission exceeds twice the noise floor (0.06 µJ). In the absence of cavitation nuclei, the 
cavitation threshold is crossed at 1.00 MPa, where the cavitation energy increases to 1.2 µJ. 
With cavitation nuclei, the threshold is crossed at a pressure as low as 0.65 MPa, where the 
inertial cavitation energy already reaches 0.2 µJ. At pressures of 0.65 MPa and above, the cavi-
tation dose in the presence of cavitation nuclei slightly exceeds that in the absence of cavita-
tion nuclei. This suggests that cavitation nuclei not only lower the cavitation threshold, but 
increase the level of cavitation activity and thus potentially the level of transdermal delivery.
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The structure of the cavitation nuclei allows them to lower the cavitation threshold. Rough 
surfaced talc particles trap air pockets on the surface, therefore a high peak rarefactional pres-
sure amplitude to draw dissolved gas out of solution is no longer required and the pressure 
required to cavitate the trapped gas, i.e. the cavitation threshold, is decreased. The results 
of this study also show that despite the ready supply of bubbles on the surface of cavitation 
nuclei, their presence does not result in higher levels of broadband emissions detected at the 
PCD. This is indicated by the lack of significant difference between the groups with and with-
out cavitation nuclei at pressures above the cavitation threshold.
Figure 4 shows the average insulin concentrations in the acceptor layers of agar samples 
exposed to various ultrasound pressures. In the absence of ultrasound, passive diffusion of 
insulin raises the average insulin concentration in the acceptor layer to around 5.8 μg ml−1. 
None of the exposures below the cavitation threshold (0.65 MPa with, 1.00 MPa without cavi-
tation nuclei) where inertial cavitation is not present enhance this concentration significantly 
(p < 0.05). For ultrasound exposure at pressures above the cavitation threshold, the concen-
tration is enhanced by over 10% compared to the control. With cavitation nuclei, figure 4 
shows that increases in insulin concentration are consistently over 20%, with up to a 40% 
enhancement observed at 1.4 MPa. The use or omission of cavitation nuclei at a given pres-
sure helps separate purely cavitation-related effects from pressure-related effects contributing 
towards transdermal delivery (such as acoustic radiation force). The results therefore suggest 
that the presence of inertial cavitation increases insulin delivery significantly, and that cavita-
tion nuclei increase insulin delivery by increasing the cavitation dose at lower pressures.
Similarly to concentration enhancement, enhancement in peak transport distance is also 
highly dependent on the presence of cavitation (figure 5). The peak transport distance increases 
Figure 3. Cavitation dose in agar samples as a function of insonation pressure, with 
and without cavitation nuclei. The results show that the use of cavitation nuclei lowers 
the cavitation threshold from between 0.65 and 1 MPa to between 0.45 and 0.65 MPa. 
The stars denote significant differences compared to the corresponding control group 
(*: p < 0.05, **: p < 0.01; two-tailed, unpaired t-test).
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by over 10% above the cavitation threshold. For 3 out of the 5 exposure settings above the 
cavitation threshold, peak transport distance increased significantly (p < 0.05), while none of 
the sub-threshold exposures exhibited significant enhancement (figure 5). The high variability 
of cavitation nuclei-associated cavitation is highlighted by the results where they are used. 
Exposures at 0.45 and 1 MPa show a high variability due to differences in (1) the distribution 
of cavitation nuclei in individual samples, and (2) the architecture of the individual cavitation 
nuclei themselves.
Mechanisms for the enhancement in peak insulin penetration distance stem from the pres-
ence of inertial cavitation (regardless of the presence or absence of cavitation nuclei) and the 
resulting formation of microstreams around and adjacent to cavitating bubbles. These micro-
streams form currents in the agar, carrying the insulin molecules further into the phantom, 
with the penetration distance of the insulin being proportional to the level of inertial cavitation 
present.
Although the cavitation threshold is lowered by the addition of cavitation nuclei, no sig-
nificant change in concentration or penetration depth was found at pressures above the cavita-
tion threshold by the addition of cavitation nuclei. Therefore, in the following experiments in 
porcine skin, talc powder was not used.
Figure 4. Insulin concentration in the acceptor layer of agar samples as a function of 
insonation pressure, with and without cavitation nuclei. The stars denote significant 
differences compared to the corresponding control group (*: p < 0.05, **: p < 0.01; 
two-tailed, unpaired t-test). There were significant differences at 0.65 MPa with talcum 
(p-value: 0.003), at 1.00 MPa without talcum powder (p-value: 0.016), and at 1.40 MPa 
with talcum powder (p-value: 0.0008). There were no significant differences between 
the results obtained with and without cavitation nuclei. Error bars indicate one standard 
deviation. The control mean (mean delivered insulin concentration for all control 
samples) was 5.80 μg ml−1. For exposures above the cavitation threshold, the mean 
insulin concentration is enhanced by at least 10%.
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3.2. Results in porcine skin—cavitation activity, transport enhancement
In porcine skin, three insonation pressures were identified that resulted in varying levels of 
cavitation energy: 0.06 µJ at 0 MPa (control), 0.16 µJ at 1.00 MPa (moderate cavitation dose), 
and 0.48 µJ at 1.40 MPa (high cavitation dose). As with the agar experiments, each exposure 
setting was employed three times, and the baseline noise level was 0.06 µJ. Cavitation nuclei 
were not used in this study, as results in the agar experiments had shown that above the cavita-
tion threshold, the presence of cavitation nuclei did not significantly enhance transport.
Figure 6 shows the fluorescent intensities of three representative porcine samples for the 
aforementioned three pressures. Unfortunately, the use of tissue made the calibration of abso-
lute insulin concentration difficult, nevertheless, the level of fluorescence intensity is expected 
to be proportional to the insulin concentration. While insulin uptake is restricted to a few 
localized regions in control samples, in the presence of inertial cavitation the spatial extent of 
insulin penetration increased both laterally along the skin surface and in terms of depth, and 
the delivered concentration is also enhanced.
Another difficulty in comparing insulin delivery in porcine skin samples was that the 
structure of the skin was inhomogeneous, with differing epidermal thicknesses and the pres-
ence of structures such as hair follicles. To minimize the impact of these inhomogeneities, 
Figure 5. Peak penetration distance in agar samples as a function of insonation pressure, 
with and without cavitation nuclei. The stars denote significant differences compared to 
the control (*: p < 0.05, **: p < 0.01; two-tailed, unpaired t-test). There were significant 
differences at 0.65 MPa with talcum (p-value: 0.003), at 1.00 MPa without cavitation 
nuclei (p-value: 0.002), and at 1.40 MPa with cavitation nuclei (p-value: 0.027). 
There were no significant differences between the results obtained with and without 
cavitation nuclei. Error bars denote one standard deviation. The control mean (mean 
peak penetration distance for all control samples) was 4.68 mm. For exposures above 
the cavitation threshold, the peak penetration distance is enhanced by at least 10%. The 
high variance at 1.00 MPa could be due to a high variance in cavitation energies.
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regions of interest used for analysis were chosen where the skin structure was similar 
across samples. Figure  7 shows average fluorescence intensities as a function of depth 
from the skin surface over three linear profiles in the selected regions of interest, at each 
exposure condition. As can be seen from the figure, the average fluorescence intensities are 
significantly higher (at some depths, over 10 times higher) than in the control. The effec-
tive penetration distances (marked by red circles on the curves) increased with increasing 
levels of cavitation energy dose, from 57.4 microns at 0 MPa (in the absence of cavitation) 
Figure 6. Fluorescence intensity images of insulin distribution in porcine skin following 
HIFU insonations without ultrasound (left), at 1 MPa (middle) and at 1.4 MPa (right). 
Insonation was performed horizontally across the images (white arrows), with the depth 
penetration dimension in the x-axis of the image. The fluorescence intensities have been 
obtained from the green channel of the fluorescence microscope images and have been 
logarithm compressed to aid interpretation.
Figure 7. Fluorescent intensity profile of fluorescent insulin as a function of the 
penetration depth, and average fluorescence intensity (inset) for three pressures. For 
each pressure, the values were calculated as the average of values obtained from three 
samples. The recorded cavitation energy for the three pressures was 0, 0.16 and 0.48 µJ 
respectively. In addition to a modest increase in penetration distance, the significant 
increase of average fluorescent intensity is thought to be mainly due to the increased 
cavitation energy present.
0 50 100 150 200 250 300
0
5
10
15
20
25
30
35
40
45
EPD 57.4µm
EPD 71.7µm
EPD 81.3µm
Penetration Depth (µm)
Fl
uo
re
sc
en
ce
 In
te
ns
ity
Fluorescence Intensity Profile
Control
1.0 MPa
1.4 MPa
Control 1.0 MPa 1.4 MPa
0
10
20
Average Fluorescent Intensity
H Feiszthuber et alPhys. Med. Biol. 60 (2015) 2421
2432
to 81.3 microns at 1.40 MPa (cavitation energy dose: 0.48 µJ), representing a 40% increase 
in penetration distance. Even more significant is the more than tenfold increase in average 
fluorescence intensity compared to control, and a fivefold increase compared to 1.00 MPa. 
Since the acoustic intensity at 1.40 MPa is less than double than that at 1.00 MPa, this 
dramatic increase is expected to be primarily due to cavitation, as opposed to other effects 
such as acoustic radiation force.
4. Conclusions
In the current work, fluorescently-stained, sonophoresis-mediated insulin transport was insti-
gated in two models, 3% agar hydrogel and porcine skin.
In agar, no enhancement in insulin delivery was observed over control (no ultrasound) 
unless broadband acoustic emissions, attributable to inertial cavitation, were detected by 
the PCD transducer. Introducing artificial cavitation nuclei in the agar gel lowered the cavi-
tation threshold from 1 to 0.65 MPa, enabling direct comparison of cavitation-mediated 
and non-cavitation-mediated delivery at the same pressure (0.65 MPa) without affecting 
other delivery mechanisms such as acoustic radiation force. In the absence of cavitation 
nuclei there was no enhancement of delivery over control at 0.65 MPa, but in the pres-
ence of nuclei, a 20% increase in penetration distance and concentration delivered were 
observed. At higher pressures above the cavitation threshold (<1 MPa), comparable levels 
of cavitation activity occur both in the absence and in the presence of cavitation nuclei, 
and the enhancement in insulin concentration reaches 40% whilst the enhancement in pen-
etration distance reaches 23%. Collectively, these results suggest that the enhancement in 
delivery is dominated by the level of cavitation activity as detected by the PCD transducer, 
rather than by the pressure amplitude used or by the presence or absence of artificial cavi-
tation nuclei.
For this reason, no artificial nuclei were used to deliver insulin to skin, instead investigating 
two pressure amplitudes (1 and 1.4 MPa) that yielded PCD cavitation energies that differed 
by a factor of 3 (0.16 versus 0.48 µJ). Similarly to the agar results, the occurrence of inertial 
cavitation caused a modest increase in effective penetration distance of up to 40%. The lower 
pressure (1 MPa) and cavitation energy resulted in a 2-fold increase in mean delivered fluores-
cent insulin over control, whilst the higher pressure (1.4 MPa) and cavitation energy yielded 
a tenfold increase over control. The results indicate a strong correlation between the level of 
broadband acoustic emissions as detected by a PCD and the observed enhancement in insulin 
concentration, suggesting that inertial cavitation plays a key role in enhancing transdermal 
insulin delivery by ultrasound.
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